Saturday, September 13, 2025

Latest

Medipharm Labs CFO Resigns From Company For Family Reasons

Medipharm Labs (TSX: LABS) this morning announced changes to their leadership team within a brief news release that was issued. The company has revealed that current chief financial officer Robert (Bobby) Kwon has resigned from the company just barely a year after taking on the role.

Appointed to the position last November, Kwon effectively took over the role on November 18, 2019. At the time, he was hyped as being a highly experienced executive from the consumer packaged goods, retail and pharmaceutical industries with over twenty five years of experience.

Kwon is said to be leaving for family reasons, with his official departure taking place at the end of the month. An interim CFO is expected to fulfill the role until a permanent replacement can be found, with the search beginning immediately. Neither an interim or permanent replacement was named in this mornings announcement.

A further announcement with respect to the interim appointee is expected to be made at the end of the month.

Medipharm Labs last traded at $0.78 on the TSX.


.Information for this briefing was found via Sedar and Medipharm Labs. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Electric Metals: The Sole US Domestic Source Of A Critical Mineral?

Marimaca Copper: The MOD Feasibility Study

Avino Q2 Earnings: Steady As She Goes

Recommended

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Goliath Resources Hits 18.58 g/t Gold Over 5.00 Metres At Surebet

Related News

Is The Medipharm Labs Supply Arrangement The Source Of Cronos’ Late Filings?

Earlier this week, Cronos Group (TSX: CRON) (NASDAQ: CRON) quietly announced that they would delay...

Wednesday, March 4, 2020, 12:12:37 PM

Medipharm Labs Posts Revenues of $13.9 Million, Net Loss of $3.5 Million For Q2 2020

Medipharm Labs (TSX: LABS) reported further disappointing quarterly results this morning, with revenues of $13.9...

Thursday, August 13, 2020, 09:25:18 AM

Will The Medipharm Labs Statement Of Claim Cause Further Issue For Hexo Corp?

It’s been revealed today by that of BNN Bloomberg that Medipharm Labs’ (TSX: LABS) statement...

Monday, January 27, 2020, 08:30:12 PM

Medipharm Labs: Canaccord Drops Target To Just $0.10

On May 16, Medipharm Labs (TSX: LABS) reported its first quarter financial results. The company...

Tuesday, May 24, 2022, 11:37:00 AM

Medipharm Labs and TerrAscend Corp Enter $27 Million Cannabis Distillate Agreement

Medipharm Labs (TSX: LABS) and TerrAscend Corp (CSE: TER) announced a significant transaction this morning,...

Wednesday, September 25, 2019, 08:56:45 AM